How is the Replimune Group Inc today?

The Replimune Group Inc today is trading in the green, up by 4.46% at 8.20.

What is Replimune Group Inc Annual Net Profit?

Replimune Group Inc Annual Net Profit fell 23.82% in the last year to $215.79 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Replimune Group Inc Price to Earning Ratio?

Replimune Group Inc Price to Earning Ratio is -2.77, which is negative.

What is Replimune Group Inc Stock Price?

Replimune Group Inc Stock Price rose 27.33% and outperformed its sector by 18.89% in the past year.

What is Replimune Group Inc Quarterly Net profit?

Replimune Group Inc Quarterly Net profit fell 29.77% YoY to $66.34 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Replimune Group Inc Debt to Equity Ratio?

Replimune Group Inc Debt to Equity Ratio of 0.2 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Replimune Group Inc Return on Equity(ROE)?

Replimune Group Inc Return on Equity(ROE) for the last financial year was -46.42%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Replimune Group Inc Mutual Fund Holding?

Replimune Group Inc Mutual Fund Holding increased by 0.01% in the last quarter to 50.25.

What is Replimune Group Inc Promoter Share Holding?

Replimune Group Inc Promoter Share Holding increased by 0.91% in the most recent quarter to 6.32%.

What is Replimune Group Inc Interest Coverage Ratio?

Replimune Group Inc Interest Coverage Ratio is -31.34, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Replimune Group Inc Institutional Holding?

Replimune Group Inc Institutional Holding increased by 1.26% in the last quarter to 104.63.

Replimune Group Inc XNAS: REPL

Replimune Group Inc Live Share Price Today, Share Analysis and Chart

Name: Replimune Group Inc: Is Infosys Ltd. worth buying?
Item: Replimune Group Inc
Rating: 0.89425
Author: Trendlyne DVM scores

about

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...

8.20 0.35 (4.46%)

51.76% Fall from 52W High

999.7K XNAS Volume

XNAS 19 May, 2025 4:00 PM (EDT)

Not Eligible

-

Expensive Valuation

10.0 / 100

Technically Bearish

25.8 / 100

No estimates available

Replimune Group Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Replimune Group Inc FAQ

How is Replimune Group Inc today?

Replimune Group Inc today is trading in the green, and is up by 4.46% at 8.20.

How has Replimune Group Inc performed historically?

Replimune Group Inc is currently trading up 4.46% on an intraday basis. In the past week the stock rose 6.36%. stock has been down -41.55% in the past quarter and rose 27.33% in the past year. You can view this in the overview section.